Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
gxpjr5CXWNpwD8nT
Listen
